• Explore /
  • Poster
  • / Lung cancer patients with HER2 mutations treated with chemotherapy and HER2 targeted drugs: Results form the EUHER2 cohort study.

Lung cancer patients with HER2 mutations treated with chemotherapy and HER2 targeted drugs: Results form the EUHER2 cohort study.

Abstract Poster

Authors

null

Julien Mazières

Hôpital Larrey CHU Toulouse, Toulouse, France

Julien Mazières , Fabrice Barlesi , Thomas Filleron , Benjamin Besse , Isabelle Monnet , Michele Beau-Faller , Solange Peters , Eric Dansin , Martin Frueh , Miklos Pless , Niki Karachaliou , Marie Wislez , Pierre Fournel , Virginie Westeel , Federico Cappuzzo , Alexis B. Cortot , Denis Moro-Sibilot , Julie Milia , Oliver Gautschi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Tumor Biology

Track

Tumor Biology

Sub Track

New Targets and New Technologies

Citation

J Clin Oncol 33, 2015 (suppl; abstr 11076)

DOI

10.1200/jco.2015.33.15_suppl.11076

Abstract #

11076

Poster Bd #

290

Abstract Disclosures

Similar Posters

First Author: Jianwen Qin

First Author: Leena Gandhi

First Author: Fang Yuan

First Author: Jeffrey A. Scott